NovaPump
NovaPump GmbH is developing and realising a leading solution for a novel right ventricular assist device (RVAD) with clear USPs (the only percutaneous device with pulsatile support).
NovaPump’s catheter-based heart pump PERKAT™ can be implanted within minutes in acute situations involving acute right heart failure, cardiogenic shock or acute right heart insufficiency and offers highly efficient pulsatile heart support in combination with the existing IABP (Intra-Aortic Balloon Pump) technology as a drive.
A perspective application of PERKAT™ as a bi-ventricular assist device (bi-VAD) is also planned for the near future.
Press releases
Press
Innovative Pulsatile Heart Pumps for Acute Patients: NovaPump secures seven-digit Financing Round
NovaPump, one of the leading developers and medical product manufacturers of percutaneous circulatory mechanical support systems (pMCS) announced the successful closing of a series A financing round with a consortium of institutional and strategic investors.
NovaPump’s PERKAT™ (PERkutane KATheterpumpe) short term MCS for acute patients achieved important milestones within the last months. With this financing round it is possible to develop the PERKAT™ products further to the first-i
Press
High Tech Gruenderfonds Invests in NovaPump GmbH
The Jena-based heart technology firm NovaPump GmbH has successfully completed a first round of financing with High Tech Gruenderfonds in July 2013. This financing will support the development of a catheter-based procedure for right heart and biventricular support.
The basic concept being developed by the team working with NovaPump founder and cardiologist Dr. Markus Ferrari and Managing Director Ronald Reich (M.Eng.) offers significant advantages over the current state of technology. NovaPump
Info & Contact
Address
Am Steinborn 103a
07749 Jena
07749 Jena
In portfolio
28. Jun 2013